Ruiping Zhao

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 316 citations

Metabolic Syndrome, Glucose Tolerance, Diabetes Management +10

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 150 citations · Full text

Inflammatory biomarkers of coronary heart disease

Ruiping Zhao · Frontiers in Bioscience-Scholar · 2017 · 116 citations

Immunology, Pathology, Coronary Artery Disease +17

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

Timothy J. Sullivan, Zhenhua Miao, Daniel J. Dairaghi et al. · American Journal of Physiology-Renal Physiology · 2013 · 86 citations · Full text

Receptor 2, Immunology, Insulin Signaling +18

Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers

Lingyan Jiang, Marie Ménard, Caroline E. Weller et al. · Cancer Research · 2023 · 61 citations

Oral Krasg12d, Tumor Biology, Krasg12d Nsclc +13